Usafsam/PH - roche immuno and ctng BPA reagents, kits and consumables
Ended Awarded Last action
- Contract number
- FA239625FB114
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Air Force
Department of Defense
- Obligated
- $297,499
Award facts
- Contract value 100% obligated
- $297,498.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- WPAFB, OH 45433, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $297,499 |
About this award
The Defense Health Agency awarded a $297,498.91 firm fixed-price blanket purchase agreement (BPA) call to Roche Diagnostics Corporation for immunochemistry and clinical testing reagents, kits, and consumables in December 2024. This contract call, designated as USAFSAM/PH - ROCHE IMMUNO AND CTNG BPA REAGENTS, KITS AND CONSUMABLES - CALL 0001, supports laboratory operations at Wright-Patterson Air Force Base, Ohio, with a completion date of May 5, 2025. The award was made without a set-aside designation, reflecting open competition in the federal marketplace. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, Indiana, specializes in in vitro diagnostic solutions and serves as a primary supplier of advanced diagnostic capabilities to the Defense Health Agency and other federal healthcare entities.
This contract represents a delivery order under Roche's existing blanket purchase agreement vehicle with the Defense Health Agency. The contractor's federal contracting history demonstrates extensive experience delivering diagnostic reagents, testing systems, and laboratory consumables across military and veterans healthcare networks. The reagents and consumables provided under this call support immunochemistry and clinical testing operations essential to the medical readiness and diagnostic capabilities of the U.S. Air Force's medical laboratory infrastructure. Roche maintains multiple active indefinite delivery contracts and blanket purchase agreements with Defense Health Agency and Veterans Integrated Service Networks, with contract values ranging from hundreds of thousands to several million dollars and extending through 2030, reflecting sustained federal demand for the company's diagnostic product portfolio.
Quick answers
Who was awarded contract FA239625FB114?
FA239625FB114 was awarded to Roche Diagnostics Corporation by Air Force (Department of Defense) on May 2, 2025.
How much is contract FA239625FB114 worth?
The government has obligated $297,499 on FA239625FB114.
Which agency awarded contract FA239625FB114?
Air Force (Department of Defense) awarded FA239625FB114, with funding from Defense Health Agency (Department of Defense).
Is contract FA239625FB114 an order under another contract?
Yes. FA239625FB114 is a BPA call under FA239625AB002, a blanket purchase agreement.
Was contract FA239625FB114 competed?
The extent of competition for FA239625FB114 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award